Regulatory PathRegulatory requirements compared

Active substance

Carboprost

Open in the medicines table

US FDA United States — FDA approvals (Drugs@FDA)

ProductStrengthForm · routeApplicantStatusFirst approved
HEMABATEEQ 0.25MG BASE/MLinjectable · injectionPFIZERPrescription9 Jan 1979
CARBOPROST TROMETHAMINEEQ 0.25MG BASE/MLinjectable · injectionDR REDDYSPrescription2 Jul 2019
CARBOPROST TROMETHAMINEEQ 0.25MG BASE/MLinjectable · injectionSUNNYPrescription25 Mar 2021
CARBOPROST TROMETHAMINEEQ 0.25MG BASE/MLinjectable · injectionAMNEALPrescription27 Jan 2022
CARBOPROST TROMETHAMINEEQ 0.25MG BASE/MLinjectable · injectionLONG GROVE PHARMSPrescription9 Aug 2022
CARBOPROST TROMETHAMINEEQ 0.25MG BASE/MLinjectable · injectionCAPLINPrescription13 Feb 2023
CARBOPROST TROMETHAMINEEQ 0.25MG BASE/MLinjectable · injectionSOLA PHARMSPrescription19 May 2023
CARBOPROST TROMETHAMINEEQ 0.25MG BASE/MLinjectable · injectionEUGIA PHARMAPrescription25 May 2023
CARBOPROST TROMETHAMINEEQ 0.25MG BASE/MLinjectable · injectionALEMBICPrescription15 Jun 2023
CARBOPROST TROMETHAMINEEQ 0.25MG BASE/MLinjectable · injectionONESOURCE SPECIALTYPrescription25 Jul 2023
CARBOPROST TROMETHAMINEEQ 0.25MG BASE/MLinjectable · injectionGLANDPrescription7 Aug 2023
CARBOPROST TROMETHAMINEEQ 0.25MG BASE/MLinjectable · injectionMICRO LABSPrescription3 Apr 2024
CARBOPROST TROMETHAMINEEQ 0.25MG BASE/MLinjectable · injectionSOMERSET THERAPS LLCPrescription27 May 2026
CARBOPROST TROMETHAMINEEQ 0.25MG BASE/MLinjectable · injectionANI PHARMSDiscontinued25 Jan 2024

Canada Canada — marketed products (Health Canada)

BrandDINStrengthForm · routeCompany
CARBOPROST TROMETHAMINE INJECTION02546779250 MCG / MLSOLUTION · INTRAMUSCULARJAMP PHARMA CORPORATION
CARBOPROST TROMETHAMINE INJECTION USP02538377250 MCG / MLSOLUTION · INTRAMUSCULARJUNO PHARMA CANADA INC.
CARBOPROST TROMETHAMINE INJECTION, USP02530430250 MCG / MLSOLUTION · INTRAMUSCULARDR REDDY'S LABORATORIES LTD
HEMABATE02230417250 MCG / MLSOLUTION · INTRAMUSCULARPFIZER CANADA ULC

Values as published by each source: SFDA human drug list (4-2026, as published by the Council of Health Insurance; indications from the CHI Daman Drug Formulary), Drugs@FDA, EMA medicines data, Health Canada Drug Product Database (Open Government Licence – Canada), CMS NADAC, NHS Drug Tariff Part VIIIA (NHSBSA Copyright, Open Government Licence v3.0), WHO Model List of Essential Medicines (CC BY 3.0 IGO; regrouped by active substance, not created by WHO), EMA PRAC, US FDA safety-related labeling changes and MHRA Drug Safety Update (Open Government Licence v3.0). Sources and reuse. Not a substitute for the official registers or the product information.